SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-23-000032
Filing Date
2023-03-28
Accepted
2023-03-28 17:27:21
Documents
13
Period of Report
2023-03-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20230324.htm   iXBRL 8-K 29425
5 GRAPHIC optn-20230324_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-23-000032.txt   186503

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20230324.xsd EX-101.SCH 1902
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20230324_lab.xml EX-101.LAB 25848
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20230324_pre.xml EX-101.PRE 13581
7 EXTRACTED XBRL INSTANCE DOCUMENT optn-20230324_htm.xml XML 3956
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 23770773
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences